Pfizer EBITDA 2010-2024 | PFE

Pfizer EBITDA for the quarter ending September 30, 2024 was $6.714B, a 516.76% decline year-over-year.

  • Pfizer 2023 EBITDA was 6.512B, a 83.72% decline from 2022.
  • Pfizer 2022 EBITDA was 40.008B, a 62.48% increase from 2021.
  • Pfizer 2021 EBITDA was 24.624B, a 90.43% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Pfizer EBITDA 2010-2024 | PFE

  • Pfizer 2023 EBITDA was 6.512B, a 83.72% decline from 2022.
  • Pfizer 2022 EBITDA was 40.008B, a 62.48% increase from 2021.
  • Pfizer 2021 EBITDA was 24.624B, a 90.43% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$690.3B
Novo Nordisk (NVO)$447.9B
Johnson & Johnson (JNJ)$372.6B
AbbVie (ABBV)$293.8B
Merck (MRK)$244.3B
Novartis AG (NVS)$210.6B
AstraZeneca (AZN)$196.5B
Sanofi (SNY)$123.1B
Innoviva (INVA)$1.2B